DCM
FOMX
DAFNA Capital Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-305,500
| Closed | -$929K | – | 94 |
|
|
2019
Q3 | $929K | Sell |
305,500
-502,500
| -62% | -$1.53M | 0.35% | 59 |
|
|
2019
Q2 | $1.92M | Hold |
808,000
| – | – | 0.72% | 38 |
|
|
2019
Q1 | $3.03M | Hold |
808,000
| – | – | 1.31% | 27 |
|
|
2018
Q4 | $2.9M | Hold |
808,000
| – | – | 1.44% | 24 |
|
|
2018
Q3 | $4.63M | Buy |
808,000
+470,000
| +139% | +$2.69M | 1.9% | 17 |
|
|
2018
Q2 | $1.69M | Buy |
338,000
+2,500
| +0.7% | +$12.5K | 0.79% | 35 |
|
|
2018
Q1 | $1.72M | Sell |
335,500
-17,241
| -5% | -$88.4K | 0.84% | 34 |
|
|
2017
Q4 | $2.12M | Buy |
352,741
+94,074
| +36% | +$565K | 1.14% | 30 |
|
|
2017
Q3 | $1.44M | Sell |
258,667
-97,000
| -27% | -$538K | 0.89% | 37 |
|
|
2017
Q2 | $1.65M | Buy |
355,667
+30,000
| +9% | +$139K | 1.18% | 30 |
|
|
2017
Q1 | $1.61M | Buy |
325,667
+57,600
| +21% | +$285K | 1.36% | 27 |
|
|
2016
Q4 | $2.98M | Sell |
268,067
-10,000
| -4% | -$111K | 2.61% | 11 |
|
|
2016
Q3 | $2.58M | Buy |
278,067
+85,500
| +44% | +$792K | 1.79% | 18 |
|
|
2016
Q2 | $1.22M | Buy |
192,567
+73,896
| +62% | +$469K | 0.97% | 35 |
|
|
2016
Q1 | $774K | Buy |
118,671
+57,901
| +95% | +$378K | 0.67% | 42 |
|
|
2015
Q4 | $493K | Buy |
+60,770
| New | +$493K | 0.44% | 57 |
|